STATINS AND RISK OF INFECTIOUS DISEASES
Besides hypolipidemic effect statins demonstrate some not-lipid (pleotropic) ones. Special attention has been paying to statin inducing reduction in bacterial infections incidence and severity, and pneumonia particularly. Results of the large studies on statin influence on infectious disease are pre...
Saved in:
Main Authors: | O. M. Drapkina, R. N. Shepel' |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins and diabetes mellitus: risks and benefits
by: O. M. Drapkina, et al.
Published: (2012-12-01) -
UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01) -
STATIN SAFETY REVISITED DATA
by: O. M. Drapkina
Published: (2015-09-01) -
THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01) -
Prevalence and predictors of statin therapy in the general working-age population
by: V. S. Kaveshnikov, et al.
Published: (2020-07-01)